AKYA

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change 0.00
Percentage change 0.00	%

Peers: ILMN PACB TWST NTLA CRSP EXAS CDNA GH FATE TXG

| Held by: VTI VXF VTWO VTWG MSSM BTEC VTHR

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.96	Insider Own	17.37%	Shs Outstand	49.84M	Perf Week	4.03%
Market Cap	64.44M	Forward P/E	-	EPS next Y	-0.69	Insider Trans	0.00%	Shs Float	41.28M	Perf Month	11.21%
Enterprise Value	120.62M	PEG	-	EPS next Q	-0.21	Inst Own	24.53%	Short Float	6.40%	Perf Quarter	5.74%
Income	-47.53M	P/S	0.81	EPS this Y	26.06%	Inst Trans	-	Short Ratio	4.60	Perf Half Y	-43.67%
Sales	79.96M	P/B	-	EPS next Y	17.05%	ROA	-35.55%	Short Interest	2.64M	Perf YTD	-43.67%
Book/sh	-0.12	P/C	2.34	EPS next 5Y	18.48%	ROE	-354.27%	52W High	3.42 -62.28%	Perf Year	-40.83%
Cash/sh	0.55	P/FCF	-	EPS past 3/5Y	1.87% -23.03%	ROIC	-	52W Low	0.93 38.56%	Perf 3Y	-89.94%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	14.14% 14.10%	Gross Margin	57.29%	Volatility	10.20% 8.09%	Perf 5Y	-
Dividend TTM	-	EV/Sales	1.51	EPS Y/Y TTM	34.87%	Oper. Margin	-46.79%	ATR (14)	0.11	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.40	Sales Y/Y TTM	-14.55%	Profit Margin	-59.45%	RSI (14)	51.90	Recom	3.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.61	EPS Q/Q	33.98%	SMA20	1.14%	Beta	1.36	Target Price	1.36
Payout	-	Debt/Eq	-	Sales Q/Q	-9.32%	SMA50	6.04%	Rel Volume	0.00	Prev Close	1.29
Employees	205	LT Debt/Eq	-	Earnings	May 12 AMC	SMA200	-36.90%	Avg Volume	574.50K	Price	1.29
IPO	Apr 16, 2021	Option/Short	Yes / No	EPS/Sales Surpr.	-50.59% -13.39%	Trades		Volume	715,252	Change	0.00%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-15-24	Downgrade	Craig Hallum	Buy → Hold	$7 → $5
Aug-06-24	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Aug-06-24	Downgrade	JP Morgan	Overweight → Neutral
Aug-06-24	Downgrade	BTIG Research	Buy → Neutral
Jun-21-24	Initiated	Craig Hallum	Buy	$7.50
Dec-14-23	Initiated	Guggenheim	Neutral
Jul-05-23	Resumed	JP Morgan	Overweight	$18
Feb-02-23	Initiated	UBS	Buy	$14
Nov-03-22	Initiated	CapitalOne	Overweight	$19
Oct-06-22	Initiated	Stephens	Overweight	$16
Jun-22-22	Initiated	BTIG Research	Buy	$16
Jan-06-22	Resumed	Piper Sandler	Overweight	$23
May-11-21	Initiated	Piper Sandler	Overweight	$28
May-11-21	Initiated	Morgan Stanley	Overweight	$26
May-11-21	Initiated	JP Morgan	Overweight	$23
May-11-21	Initiated	Canaccord Genuity	Buy	$25

Show Previous Ratings

Jul-11-25 05:00PM	Quanterix Corporation Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Jul-08-25 09:07AM	Quanterix Completes Acquisition of Akoya Biosciences, Creating the First Integrated Platform Capable of Measuring Biomarkers Across the Blood and Tissue Continuum (Business Wire)
May-23-25 02:21PM	Kent Lake Responds to Quanterix's Post-Effective Amendment and Akoya's Superior $1.40-per-Share Alternative Proposal (PR Newswire)
09:10AM	New Data and Deal Flow Signal a Turning Point for Precision-Driven Cancer Biotechs (PR Newswire)
May-12-25 05:30PM	Akoya Biosciences (AKYA) Reports Q1 Loss, Misses Revenue Estimates (Zacks) +5.45% -12.50%
04:36PM	Loading…
04:36PM	Akoya: Q1 Earnings Snapshot (Associated Press Finance)
04:05PM	Akoya Biosciences Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-08-25 05:10PM	Arcellx, Inc. (ACLX) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
May-05-25 10:00AM	Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Q1 Release (Zacks)
May-01-25 04:23AM	Zealand Pharma AS (ZLDPF) Stock Jumps 8.0%: Will It Continue to Soar? (Zacks)
Apr-30-25 08:00AM	Kent Lake Issues Statement on Quanterix's Blatant Disregard for Will of Shareholders (Business Wire) -5.51%
Apr-29-25 07:00AM	Quanterix and Akoya Biosciences Announce Amended Merger Agreement (Business Wire)
Apr-24-25 08:00AM	Akoya Biosciences Expands Biopharma Service Portfolio with New ADC Breast Cancer Assay and Real-world IO60 Insights at AACR 2025 (GlobeNewswire)
08:00AM	Akoya Biosciences and Enable Medicine Launch the Largest Commercially Available Single-Cell Spatial Proteomics Atlas (GlobeNewswire)
Apr-23-25 08:00AM	Akoya Biosciences and Singapore Translational Cancer Consortium (STCC) Partner on SUPER Study Designed to Advance Cancer Immunophenotyping for Patients in Singapore (GlobeNewswire) +8.55%
08:30AM	Loading…
Apr-17-25 08:30AM	Kent Lake Files Definitive Proxy Statement and Sends Letter to Quanterix Shareholders (Business Wire)
Apr-14-25 08:00AM	Tikvah Management Calls on Quanterix to Explain the Egregious Terms of Convertible Notes Purchased from Akoya Biosciences (Business Wire)
Apr-07-25 08:15AM	Kent Lake Comments on Quanterix's Value Destructive Bridge Financing for Financially Troubled Akoya (Business Wire)
Apr-02-25 09:41AM	Quanterix: Still Many, Many Questions (Seeking Alpha)
08:00AM	Akoya Biosciences and Team SAMBAI Announce Selection of the PhenoCycler -Fusion as the Foundational Spatial Proteomics Technology for Large-Scale Study to Address Cancer Inequities (GlobeNewswire)
Mar-24-25 11:03AM	Tikvah Management Announces Intention to Vote AGAINST Quanterix's Proposed Merger with Akoya Biosciences (Business Wire)
Mar-18-25 09:18AM	Q4 2024 Quanterix Corp Earnings Call (Thomson Reuters StreetEvents)
03:01AM	Quanterix Corp (QTRX) Q4 2024 Earnings Call Highlights: Strong Revenue Growth Amid Market Challenges (GuruFocus.com)
Mar-17-25 05:10PM	Akoya Biosciences (AKYA) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:15PM	Akoya: Q4 Earnings Snapshot (Associated Press Finance)
04:00PM	Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today's Earnings Call (Business Wire)
04:00PM	Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results (GlobeNewswire)
Feb-18-25 03:40PM	Kent Lake Issues Letter to Quanterix Shareholders Regarding Opposition to the Company's Proposed Merger with Akoya Biosciences (Business Wire) -7.79%
Feb-06-25 08:15AM	Akoya Biosciences unveils strategic product roadmap (TipRanks) -7.04%
Feb-05-25 08:00AM	Akoya Biosciences Unveils Strategic Product Roadmap, Powered by the New IO60 and Upcoming Neurobiology Panels (GlobeNewswire)
06:00AM	Loading…
Jan-28-25 06:00AM	Akoya Biosciences Selects Argonaut Manufacturing Services as IVD Manufacturing Partner (Business Wire)
Jan-10-25 07:00AM	Quanterix to Acquire Akoya Biosciences, Creating the First Integrated Solution for Ultra-Sensitive Detection of Blood- and Tissue-Based Protein Biomarkers (Business Wire) +13.91%
Dec-10-24 08:15AM	Akoya Biosciences and NeraCare Enter into an Exclusive Global License Agreement for the Development and Commercialization of the Immunoprint Test for Early-Stage Melanoma Patient Treatment Decisions (GlobeNewswire)
Dec-09-24 08:00AM	Nature Methods Names Spatial Proteomics 'Method of the Year 2024' Akoya Biosciences Celebrates Industry Milestone (GlobeNewswire) +5.66%
Dec-02-24 10:18AM	Biotech Advances Drive Cancer Research as Global Rates Continue Upward Trend (PR Newswire)
Nov-15-24 02:18AM	Akoya Biosciences Inc (AKYA) Q3 2024 Earnings Call Highlights: Navigating Revenue Challenges ... (GuruFocus.com) -23.00%
Nov-14-24 05:10PM	Akoya Biosciences (AKYA) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:09PM	Akoya: Q3 Earnings Snapshot (Associated Press Finance)
04:00PM	Akoya Biosciences Reports Third Quarter 2024 Financial Results (GlobeNewswire)
Nov-13-24 07:26AM	Akoya Biosciences Inc (AKYA) Q3 2024 Earnings Report Preview: What To Look For (GuruFocus.com)
Nov-05-24 08:00AM	Akoya Biosciences Unveils a New Era in Spatial Content Innovation with the PhenoCode Discovery IO60 and Mouse FFPE IO Panel (GlobeNewswire) +17.94%
Oct-28-24 08:30AM	Akoya Bioscience to Report Third Quarter 2024 Financial Results on November 14, 2024 (GlobeNewswire)
Oct-07-24 08:00AM	Akoya's Leading Spatial Proteomics Platforms Selected for Use by Ground-Breaking UK-Based MANIFEST Consortium to Revolutionize Cancer Immunotherapy (GlobeNewswire) +15.47%
Oct-03-24 04:00PM	Akoya Biosciences Announces Scott Mendel as Chairman of the Board of Directors (GlobeNewswire) +8.81%
Aug-05-24 08:59PM	AKYA Stock Earnings: Akoya Biosciences Meets EPS, Misses Revenue for Q2 2024 (InvestorPlace) -6.51%
05:10PM	Akoya Biosciences (AKYA) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
04:07PM	Akoya: Q2 Earnings Snapshot (Associated Press Finance)
04:00PM	Akoya Biosciences Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-15-24 04:00PM	Akoya Biosciences to Report Second Quarter 2024 Financial Results on August 5, 2024, and Participate at Two Upcoming Investor Conferences (GlobeNewswire) +13.30%
May-15-24 08:02AM	Piper Sandler Cuts Akoya Biosciences Price Target to $6 From $8, Maintains Overweight Rating (MT Newswires)
May-14-24 01:55PM	Top Midday Decliners (MT Newswires) -29.61%
09:01AM	Akoya Biosciences Inc (AKYA) Q1 2024 Earnings Call Transcript Highlights: Navigating Challenges ... (GuruFocus.com)
08:14AM	Top Premarket Decliners (MT Newswires)
07:34AM	Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday (InvestorPlace)
May-13-24 08:54PM	AKYA Stock Earnings: Akoya Biosciences Misses EPS, Misses Revenue for Q1 2024 (InvestorPlace)
05:35PM	Akoya Biosciences (AKYA) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:36PM	Akoya: Q1 Earnings Snapshot (Associated Press Finance)
04:00PM	Akoya Biosciences Reports First Quarter 2024 Financial Results (GlobeNewswire)
May-09-24 08:00AM	Akoya Biosciences and NeraCare Enter into an Exclusive Agreement to Enable Personalized Therapy Selection for Early-Stage Melanoma Patients (GlobeNewswire) +9.00%
May-06-24 10:00AM	Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
08:00AM	Akoya Biosciences Opens Operations and Manufacturing Center of Excellence in Marlborough, Massachusetts (GlobeNewswire)
May-02-24 08:00AM	Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval for KR-HT5 in China to Support Next Generation Pathology Clinical Workflows (GlobeNewswire)
Apr-22-24 04:05PM	Akoya to Report First Quarter 2024 Financial Results on May 13th, 2024 (GlobeNewswire)
Apr-05-24 08:00AM	Akoya Biosciences Showcases Spatial Biology 2.0 Solutions at AACR Annual Meeting with Case Studies Demonstrating Unprecedented Speed and Scale (GlobeNewswire)
Mar-05-24 09:52AM	Akoya Biosciences, Inc. (NASDAQ:AKYA) Q4 2023 Earnings Call Transcript (Insider Monkey) -14.72%
07:00AM	Q4 2023 Akoya Biosciences Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-04-24 08:51PM	AKYA Stock Earnings: Akoya Biosciences Beats EPS, Beats Revenue for Q4 2023 (InvestorPlace)
05:31PM	Akoya Biosciences Inc (AKYA) Reports Record Q4 Revenue and Sets Positive 2024 Outlook (GuruFocus.com)
05:15PM	Akoya Biosciences (AKYA) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:21PM	Akoya: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Akoya Reports Record Revenue in the Fourth Quarter of 2023 and Provides Full Year 2024 Financial Outlook (GlobeNewswire)
Feb-08-24 04:05PM	Akoya to Report Fourth Quarter and Full Year 2023 Financial Results on March 4th, 2024 and Participate at an Upcoming Investor Conference (GlobeNewswire)
Feb-07-24 04:13AM	Strength Seen in Akoya (AKYA): Can Its 7.4% Jump Turn into More Strength? (Zacks)
Jan-18-24 08:00AM	Akoya Biosciences' Technology Enables Queensland Spatial Biology Centre to Revolutionize the Diagnosis and Treatment of Cancer and Other Diseases (GlobeNewswire)
Jan-10-24 08:00AM	Akoya Biosciences Announces that Garry Nolan, Ph.D., James Allison, Ph.D., and Padmanee Sharma, M.D., Ph.D., Join Newly Created Scientific Advisory Board (GlobeNewswire)
Jan-08-24 01:07AM	Akoya Biosciences Issues Preliminary Revenue Results; Issues 2024 Guidance (RTT News) +20.09%
Jan-07-24 08:00AM	Akoya Biosciences Deploys the MaxFuse Algorithm Co-Developed by Dr. Garry Nolan and His Laboratory at Stanford University for Multiomic Integration of Spatial and Single-cell Data on the Enable Medicine Platform (GlobeNewswire)
08:00AM	Akoya Biosciences Announces Preliminary Financial Results for the Fourth Quarter and Full Year 2023 and Provides 2024 Outlook (GlobeNewswire)
08:00AM	Akoya Biosciences and Thermo Fisher Scientific Announce a License and Distribution Agreement to Deliver Spatial Multiomics Workflow (GlobeNewswire)
Jan-05-24 08:34AM	How Akoya Biosciences (AKYA) Stock Stands Out in a Strong Industry (Zacks)
Dec-27-23 09:55AM	How Much Upside is Left in Akoya (AKYA)? Wall Street Analysts Think 86% (Zacks)
Dec-20-23 08:05AM	Akoya to Participate at 42nd Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Nov-12-23 10:51AM	Akoya Biosciences, Inc. (NASDAQ:AKYA) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-09-23 10:25AM	Q3 2023 Akoya Biosciences Inc Earnings Call (Thomson Reuters StreetEvents) +10.90%
Nov-08-23 05:51PM	Akoya Biosciences Inc (AKYA) Reports 34% Year-Over-Year Revenue Growth in Q3 2023 (GuruFocus.com)
04:05PM	Akoya: Q3 Earnings Snapshot (Associated Press Finance)
04:00PM	Akoya Reports Record Revenue in the Third Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance (GlobeNewswire)
Nov-02-23 08:00AM	Akoya to Participate at Three Upcoming Investor Conferences (GlobeNewswire) +7.92%
Nov-01-23 10:01AM	Akoya Biosciences (AKYA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Oct-31-23 09:00AM	Akoya Biosciences to Showcase New Spatial Biology 2.0 Solutions and Spatial Phenotyping Data at SITC 2023 (GlobeNewswire)
Oct-17-23 10:22AM	Akoya Biosciences Announces Peer-Reviewed Publication Using Ultrahigh-Plex Spatial Phenotyping of Head and Neck Cancer to Identify Distinct Immune and Metabolic Signatures (GlobeNewswire) +5.41%
Oct-11-23 04:05PM	Akoya to Report Third Quarter 2023 Financial Results on November 8th, 2023 (GlobeNewswire) -8.21% -6.10%
Sep-19-23 08:00AM	Akoya Biosciences Sets a New Standard for Scaling Spatial Biology with the Launch of 2.0 Platforms (GlobeNewswire)
Aug-17-23 09:56AM	10 Healthcare Stocks with Insider Buying (Insider Monkey)
Aug-08-23 12:38PM	Q2 2023 Akoya Biosciences Inc Earnings Call (Thomson Reuters StreetEvents)
Aug-07-23 06:15PM	Akoya Biosciences (AKYA) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
05:02PM	Akoya: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Akoya Reports Record Revenue in the Second Quarter of 2023 and Reiterates Full Year 2023 Revenue Guidance (GlobeNewswire)
08:05AM	Akoya Biosciences Announces Milestone of 1,000 Peer-Reviewed Publications Citing Use of its Spatial Biology Technologies (GlobeNewswire)
Aug-06-23 10:57AM	Private equity firms account for 49% of Akoya Biosciences, Inc.'s (NASDAQ:AKYA) ownership, while institutions account for 29% (Simply Wall St.)

Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery and clinical research. The company offers comprehensive single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and treatment response. Akoya offers two distinct solutions, the CODEX and Phenoptics platforms, to serve the diverse needs of researchers across discovery, translational and clinical research. The company was founded by Garry Nolan, Yury Goltsev and Nikolay Samusik in 2015 and is headquartered in Marlborough, MA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Akoya Biosciences Inc

Upgrade your FINVIZ experience